×
For best experience we recommend to activate Javascript in your browser.
HCK antibody (N-Term)
This anti-HCK antibody is a Rabbit Polyclonal antibody detecting HCK in WB and ELISA. Suitable for Human.
Quick Overview for HCK antibody (N-Term) (ABIN2279460)
Target
See all HCK Antibodies
HCK
(Hemopoietic Cell Kinase (HCK))
Reactivity
All reactivities for HCK antibodies
Human
Host
All hosts for HCK antibodies
Rabbit
Clonality
All clonalities for HCK antibodies
Polyclonal
Conjugate
All conjugates for HCK antibodies
This HCK antibody is un-conjugated
Application
All applications for HCK antibodies
Western Blotting (WB), ELISA
Product Details anti-HCK Antibody
(hide)
Binding Specificity
All epitopes for HCK antibodies
AA 71-101, N-Term
Cross-Reactivity
Human
Cross-Reactivity (Details)
Calculated cross reactivity: Hu
Characteristics
Hck, NT (Hck, Tyrosine-protein kinase HCK, B Cell/myeloid kinase, Hematopoietic cell kinase, Hemopoietic cell kinase, p56-HCK/p59-HCK)
Purification
Purified by Protein A affinity chromatography.
Immunogen
Mouse Hck antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 71-101 amino acids from the N-terminal region of Mouse Hck.
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working conditions should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
-20°C
Target Details for HCK
(hide)
Target
HCK
(Hemopoietic Cell Kinase (HCK))
Alternative Name
Hck
NCBI Accession
NP_034537 , NP_001165588
UniProt
P08103
Pathways
Activation of Innate immune Response , Cellular Response to Molecule of Bacterial Origin , Regulation of Actin Filament Polymerization , CXCR4-mediated Signaling Events , Thromboxane A2 Receptor Signaling
Recently viewed
(hide)
Chat with us , powered by LiveChat